Trial Site Detail

 

Drug:
CB-839
Trial:
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors
Conditions: Solid Tumors
Trial Status:
Active, not recruiting

 

UCSF Helen Diller Family Comprehensive Cancer Center

1450 3rd St.     
San Francisco , CA 94115
USA

 

Principal Investigator:
Pamela Munster
Contact:
Ilaria Mastroserio 415-514-6245 Ilaria.Mastroserio@ucsf.edu
Activation Status of this Site:
Closed
Notes about this Site:
UCSF Helen Diller Family Comprehensive Cancer Center Website:
http://128.218.158.34:8000/trials/index.php

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.